- Home
- NEOG vs RYTM Comparison
NEOG vs RYTM Comparison
Compare NEOG & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOG
- RYTM
- Stock Information
- Founded
- NEOG 1981
- RYTM 2008
- Country
- NEOG United States
- RYTM United States
- Employees
- NEOG N/A
- RYTM N/A
- Industry
- NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- NEOG Health Care
- RYTM Health Care
- Exchange
- NEOG Nasdaq
- RYTM Nasdaq
- Market Cap
- NEOG 3.2B
- RYTM 3.2B
- IPO Year
- NEOG 1989
- RYTM 2017
- Fundamental
- Price
- NEOG $7.93
- RYTM $46.39
- Analyst Decision
- NEOG Buy
- RYTM Strong Buy
- Analyst Count
- NEOG 2
- RYTM 12
- Target Price
- NEOG $14.00
- RYTM $68.58
- AVG Volume (30 Days)
- NEOG 4.8M
- RYTM 543.7K
- Earning Date
- NEOG 04-09-2025
- RYTM 05-06-2025
- Dividend Yield
- NEOG N/A
- RYTM N/A
- EPS Growth
- NEOG N/A
- RYTM N/A
- EPS
- NEOG N/A
- RYTM N/A
- Revenue
- NEOG $913,828,000.00
- RYTM $130,126,000.00
- Revenue This Year
- NEOG $0.46
- RYTM $45.46
- Revenue Next Year
- NEOG $4.12
- RYTM $63.04
- P/E Ratio
- NEOG N/A
- RYTM N/A
- Revenue Growth
- NEOG N/A
- RYTM 68.06
- 52 Week Low
- NEOG $8.04
- RYTM $35.17
- 52 Week High
- NEOG $18.58
- RYTM $68.58
- Technical
- Relative Strength Index (RSI)
- NEOG 29.45
- RYTM 39.41
- Support Level
- NEOG $8.04
- RYTM $48.23
- Resistance Level
- NEOG $8.69
- RYTM $54.67
- Average True Range (ATR)
- NEOG 0.38
- RYTM 2.42
- MACD
- NEOG -0.04
- RYTM -0.28
- Stochastic Oscillator
- NEOG 1.89
- RYTM 9.06
About NEOG Neogen Corporation
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.